日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.

肿瘤特异性 HORMAD1 表达扰乱有丝分裂停滞,并导致对有丝分裂激酶抑制剂的敏感性。

Walker Callum, Kollarovic Gabriel, Weekes Daniel, Trendell Jennifer, Hoffmann Ricarda M, Martin Alexia, Ferro Riccardo, Navarro-Llinas Blanca, Hitchen Luke, Pardo Calvo Mercedes, Balan Nicolae, Kemp Harriet, Carroll Alexandra, Davidson Kathryn, Nath Sarmi, D'Uonno Nadja, Lu Ruifang, Starling Chris, Otten Marieke, Iakobachvili Nino, Marcozzi Chiara, Rahman Ilhan, Quist Jelmar, Yu Lu, Krastev Dragomir B, Amodeo Valeria, Roxanis Ioannis, Grigoriadis Anita, Bayliss Richard, Choudhary Jyoti, Haider Syed, Pines Jonathon, Pettitt Stephen J, Lord Christopher J, Tutt Andrew N J

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

采用 MF59 佐剂的交叉保护性 β-SARS-CoV-2 病毒样颗粒疫苗的临床前开发。

Earnest Linda, Ruiz Daniel Fernandez, Edeling Melissa A, Montoya Julio Carrera, Yap Ashley Huey Yiing, Wong Chinn Yi, Holz Lauren E, Gras Stephanie, Collett Simon, Cooney James P, Davidson Kathryn C, Grimley Samantha L, Purcell Damian F J, Roberts Jason, Mumford Jamie, Tan Chee Wah, Wang Lin-Fa, Godfrey Dale I, Frieman Matthew, Hans Dhiraj, Vincan Elizabeth, Anderson Danielle E, Subbarao Kanta, Pellegrini Marc, Mackenzie Jason M, Rockman Steven, Heath William R, Torresi Joseph

A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.

一种新型PLpro抑制剂改善了新冠肺炎长期症状的临床前模型的结果

M Bader Stefanie, Calleja Dale J, Devine Shane M, Kuchel Nathan W, Lu Bernadine G C, Wu Xinyu, Birkinshaw Richard W, Bhandari Reet, Loi Katie, Volpe Rohan, Khakham Yelena, Au Amanda E, Blackmore Timothy R, Mackiewicz Liana, Dayton Merle, Schaefer Jan, Scherer Lena, Stock Angus T, Cooney James P, Schoffer Kael, Maluenda Ana, Kleeman Elizabeth A, Davidson Kathryn C, Allison Cody C, Ebert Gregor, Chen Gong, Katneni Kasiram, Klemm Theresa A, Nachbur Ueli, Georgy Smitha Rose, Czabotar Peter E, Hannan Anthony J, Putoczki Tracy L, Tanzer Maria, Pellegrini Marc, Lechtenberg Bernhard C, Charman Susan A, Call Melissa J, Mitchell Jeffrey P, Lowes Kym N, Lessene Guillaume, Doerflinger Marcel, Komander David

IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.

IL-1β 驱动 SARS-CoV-2 引起的疾病,与炎症小体和细胞焦亡信号无关

M Bader Stefanie, Scherer Lena, Schaefer Jan, Cooney James P, Mackiewicz Liana, Dayton Merle, Georgy Smitha Rose, Davidson Kathryn C, Allison Cody C, Herold Marco J, Strasser Andreas, Pellegrini Marc, Doerflinger Marcel

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses

一种新型嵌合冠状病毒刺突蛋白疫苗,结合了SARS-CoV-2的受体结合域(RBD)和HKU-1的支架结构域,可诱导产生强效的中和抗体反应。

Zoest, Veronica P; Lee, Wen Shi; Murdiyarso, Lydia; Burmas, Lauren; Pymm, Phillip; Esterbauer, Robyn; Kelly, Andrew; Kelly, Hannah G; Barber-Axthelm, Isaac; Cooney, James P; Davidson, Kathryn C; Dayton, Merle; McAleese, Courtney E; Gillard, Marianne; Hughes, Karen; Jones, Martina L; Pellegrini, Marc; Tham, Wai-Hong; Hughes, Ben; Kent, Stephen J; Wheatley, Adam K; Juno, Jennifer A; Tan, Hyon-Xhi

Unveiling urban governance diversity: Clustering cities based on mitigation actions

揭示城市治理多样性:基于缓解措施对城市进行聚类分析

Mokhles, Sombol; Davidson, Kathryn; Acuto, Michele

mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting

编码SARS-CoV-2突变体膜锚定RBD的mRNA疫苗可诱导强烈的体液免疫反应,并能克服免疫印迹。

Al-Wassiti, Hareth A; Fabb, Stewart A; Grimley, Samantha L; Kochappan, Ruby; Ho, Joan K; Wong, Chinn Yi; Tan, Chee Wah; Payne, Thomas J; Takanashi, Asuka; Lee, Chee Leng; Mugan, Rekha Shandre; Sicilia, Horatio; Teo, Serena L Y; McAuley, Julie; Ellenberg, Paula; Cooney, James P; Davidson, Kathryn C; Bowen, Richard; Pellegrini, Marc; Rockman, Steven; Godfrey, Dale I; Nolan, Terry M; Wang, Lin-Fa; Deliyannis, Georgia; Purcell, Damian F J; Pouton, Colin W

Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening

通过全面的功能筛查确定 HCV E1E2 的脆弱位点

Jennifer M Pfaff-Kilgore, Edgar Davidson, Kathryn Kadash-Edmondson, Mayda Hernandez, Erin Rosenberg, Ross Chambers, Matteo Castelli, Nicola Clementi, Nicasio Mancini, Justin R Bailey, James E Crowe Jr, Mansun Law, Benjamin J Doranz

Acid Suppression Does Not Improve Laryngomalacia Outcomes but Treatment for Oropharyngeal Dysphagia Might Be Protective

抑酸治疗并不能改善喉软化症的预后,但治疗口咽吞咽困难可能具有保护作用。

Duncan, Daniel R; Larson, Kara; Davidson, Kathryn; Williams, Nina; Liu, Enju; Watters, Karen; Rahbar, Reza; Rosen, Rachel L

Establishment of a Pediatric COVID-19 Biorepository: Unique Considerations and Opportunities for Studying the Impact of the COVID-19 Pandemic on Children

建立儿科 COVID-19 生物样本库:研究 COVID-19 疫情对儿童影响的独特考虑和机会

Rosiane Lima, Elizabeth Gootkind, Denis De La Flor, Laura Yockey, Evan Bordt, Paolo D'Avino, Shen Ning, Katerina Heath, Katherine Harding, Jaclyn Zois, Grace Park, Margot Hardcastle, Kathleen A Grinke, Sheila Grimmel, Pamela J Forde, Susan P Davidson, Kathryn E Hall, Anne Neilan, Juan D Matute, Paul